BPC-157 is investigated for cytoprotective signaling and experimentally reported angiogenesis-associated repair mechanisms in preclinical models
Because peptides are biologically active and structurally sensitive, correct preparation and administration are essential
The risk may be increased if this product is used for an extended time, especially in newborns or in people with kidney disease
We do not treat patients with a known hypersensitivity to cobalamin or cobalt, patients with a rare condition called Leber's optic atrophy, or patients who are pregnant or breastfeeding without GP sign-off
TB-500 + BPC-157 Stack (5 mg Vials) Dosage Protocol TB-500 Dosage Chart TB-500 is dosed at 1.25 mg weekly via subcutaneous injection in educational protocols
Subcutaneous injections go into your fat, often in the belly, thigh or upper arm